跳至主要内容
临床试验/NCT05581316
NCT05581316已完成不适用

An Investigation of the Effect of Types of Catheters on Bloodstream Infection in Patients With Major Burns: Prediction With Procalcitonin and Prognosis

Hasan Kalyoncu University2 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
34
试验地点
2
主要终点
Level of procalcitonin

研究概览

简要总结

Bloodstream infections and catheter-related infections frequently occur in burn patients. It is important to correctly assess and manage these infections. The present study aimed to investigate the effects of catheter types used in major burn patients on bloodstream infections as well as to predict sepsis status and manage its prognosis using a procalcitonin biomarker.

详细描述

Aim:

Bloodstream infections and catheter-related infections frequently occur in burn patients. It is important to correctly assess and manage these infections. The present study aimed to investigate the effects of catheter types used in major burn patients on bloodstream infections as well as to predict sepsis status and manage its prognosis using a procalcitonin biomarker.

Materials and Methods:

A total of 34 patients admitted to the intensive care unit of the Burn Center, December 25th State Hospital, Ministry of Health, between 2019 and 2022, were included in the study conducted at the Department of Physiotherapy and Rehabilitation, Faculty of Health Sciences, Hasan Kalyoncu University.

Study inclusion criteria

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Conscious and cooperative (based on the Glasgow coma score; eyes open spontaneously (E): 4, obeys commands (M): 6, oriented verbal (V) response: 5; and E4M6V5);
  • Enterally fed, aged over 18 years;
  • No antibiotic treatment from hospitalization to discharge;
  • Meets the major burn class standards defined by the American Burn Association; and
  • Stable hemodynamic values and vital signs with no need for inotropic medication.

排除标准

  • Organ dysfunctions or multiple organ failures • Antibiotics treatment

结局指标

主要结局

Level of procalcitonin

时间窗: Each participant will be evaluated for 4 weeks

blood test

Level of leukocyte

时间窗: Each participant will be evaluated for 4 weeks

blood test

Level of thrombocyte

时间窗: Each participant will be evaluated for 4 weeks

blood test

次要结局

未报告次要终点

研究者

发起方
Hasan Kalyoncu University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Murat Ali ÇINAR

assistive professor

Hasan Kalyoncu University

研究点 (2)

Loading locations...

相似试验